At what age should children receive the yellow fever vaccine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yellow Fever Vaccine Age Recommendation

Children should receive the yellow fever vaccine starting at 9 months of age. This is the standard minimum age for routine vaccination based on ACIP guidelines and FDA labeling 1, 2.

Age-Based Vaccination Guidelines

Standard Vaccination Age: ≥9 Months

  • The yellow fever vaccine is indicated for persons 9 months of age and older 2
  • At 9 months, the risk of serious neurologic adverse events (YEL-AND) drops substantially compared to younger infants 1

High-Risk Infants (6-8 Months): Use with Extreme Caution

  • Age 6-8 months is classified as a PRECAUTION, not a routine recommendation 1
  • Infants <6 months have dramatically elevated rates of vaccine-associated neurotropic disease (YEL-AND): 50-400 cases per 100,000 vaccinated 1
  • Two cases of YEL-AND have been reported in the 6-8 month age group 1
  • Travel should be postponed or avoided whenever possible for infants 6-8 months old 1
  • If travel to endemic areas is unavoidable for 6-8 month olds, the decision requires careful risk-benefit analysis weighing YFV exposure risk against adverse event risk 1

Contraindication: <6 Months

  • Never vaccinate infants younger than 6 months due to unacceptably high rates of serious neurologic complications 1

Important Clinical Considerations

Booster Timing

Recent research suggests that immunity may wane in children vaccinated at young ages:

  • Seroprotection rates in children vaccinated at 9-23 months drop to only 47% after 10+ years 3
  • The pooled vaccine response rate declines notably after 18 months post-vaccination in pediatric populations 4
  • Consider booster dosing at 4 years of age, particularly in endemic areas, as supported by Brazilian National Immunization Program recommendations 5

Key Safety Points

  • The vaccine is generally safe in children ≥9 months with no unexpected safety concerns identified in comprehensive surveillance 6
  • Common adverse events include diarrhea (34%), fever (33%), and rash (18%), but these are typically non-serious 6
  • No vaccine-related serious adverse events were identified in children 9-23 months in recent trials 6

Certificate Validity

  • The International Certificate of Vaccination becomes valid 10 days after vaccination 2
  • This timing is critical for international travel requirements

Bottom line: Vaccinate at 9 months or older for routine protection. Never vaccinate before 6 months. Use extreme caution and only when absolutely necessary for the 6-8 month age group.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.